Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neurodevelopmental Disorders: full-pipeline trial registry
17 of 28 indexed Neurodevelopmental Disorders trials are currently recruiting.
Corpus placement: #577 of 28,707 conditions by registered trial count.
28 US clinical trials · 17 currently recruiting · #577 of 28,707 conditions by registered trial count
Neurodevelopmental Disorders: 28 US clinical trials tracked, 17 recruiting.
Neurodevelopmental Disorders is the subject of 28 registered US clinical trials on ClinicalTrials.gov, 17 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Health Resources and Services Administration (HRSA), running 3 of these trials.
Enrollment posture brief
Registry condition neurodevelopmental-disorders
OPEN 17 | RECR 61% | LATE 1 | EARLY 1 | RANK #577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: HIV Prevention (61% recruiting · 33 trials)
Neurodevelopmental Disorders lists 17 open slots (61% of 28 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neurodevelopmental Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neurodevelopmental Disorders is recruiting above its size-band peers.
17 of 28 indexed trials (60.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Neurodevelopmental Disorders trials is spread across many organizations.
Health Resources and Services Administration (HRSA) accounts for 3 of 28 trials (10.7%). 23 distinct sponsors appear on at least one study for this condition label.
-
Typical Neurodevelopmental Disorders enrolment sits around 150 participants.
Median target enrolment is 150 among the 28 trials that report a genuine target (sentinel values excluded). 10 of those (35.7%) plan for fewer than 100 participants.
-
Neurodevelopmental Disorders splits between interventional and observational designs.
15 interventional and 13 observational studies make up this index (53.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
28 total, page 1 of 1
Reducing Missed Appointments
Hugo W. Moser Research Institute at Kennedy Krieger
NCT06915480
Rett Syndrome Registry
International Rett Syndrome Foundation
NCT05432349
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
University of Pennsylvania
NCT04321200
Longitudinal Study of Neurogenetic Disorders
Columbia University
NCT03492060
Patterns of Neurodevelopmental Disorders
Richard Frye
NCT06213090
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder
University of Pittsburgh
NCT06776341
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Ann & Robert H Lurie Children's Hospital of Chicago
NCT05336890
Physical Activity and Community EmPOWERment Project
University of North Carolina, Chapel Hill
NCT06740162
School-based Paraeducator Education for Engagement at Recess
University of Washington
NCT06559267
Genetic Inclusion by Virtual Evaluation
Baylor College of Medicine
NCT05318222
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
University of Utah
NCT05767385
Word Learning From Parentese in Autistic Children
The University of Texas at Dallas
NCT06649916
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
American Federation of Medical Synergetics
NCT03222375
Childhood Outcomes of Preterm Brain Abnormalities
Children's Hospital Los Angeles
NCT03410810
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
Children's Hospital Medical Center, Cincinnati
NCT06175104
Motor-voice Assessment in Infants (MAMI)
Ohio State University
NCT06807203
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Royal Devon and Exeter NHS Foundation Trust
NCT05751525
AIRB-4: Self-Determined Learning Model of Instruction
Health Resources and Services Administration (HRSA)
NCT04972851
AIR-B4: Mind the Gap
Health Resources and Services Administration (HRSA)
NCT04972825
AIR-B4: Remaking Recess (RR)
Health Resources and Services Administration (HRSA)
NCT04972838
Wearable Sensors and Video Recordings to Monitor Motor Development
Shirley Ryan AbilityLab
NCT03770832
Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development
Brigham and Women's Hospital
NCT03977259
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
Yale University
NCT02118649
Evaluation of a Novel Intervention for Infants At Risk for Neurodevelopmental Disorders
University of North Carolina, Chapel Hill
NCT03388294
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children
NYU Langone Health
NCT04108273
CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Children's Hospital Medical Center, Cincinnati
NCT00783783
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
NYU Langone Health
NCT03148782
Experience With a Pediatric Summer Intensive Therapy Program
University of Missouri-Columbia
NCT04891328
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neurodevelopmental Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neurodevelopmental Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neurodevelopmental Disorders page
28 registered trials, 17 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 17 Neurodevelopmental Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Health Resources and Services Administration (HRSA) sponsors the most Neurodevelopmental Disorders trials on record, review their full trial history before evaluating a specific study. See Health Resources and Services Administration (HRSA)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neurodevelopmental Disorders condition card totals 28 registered trials; most-linked intervention OST Intervention for participants with Organizational skill difficulties; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.